Social disparities in breast and cervical cancer preventive practices

European Journal of Cancer Prevention

Volumn 16, Issue 4, 2007, Pages 372-379

  Cabeza, Elena ^a,b,d   Esteva, Magdalena ^c   Pujol, Angels ^a   Thomas, Vicenç ^c   Sánchez Contador, Carmen ^a  

^a Balearic Department of Health   (Spain)

^b Epidemiology Unit   (Spain)

^c Primary Health Care Mallorca District   (Spain)

^d Dirección General de Salud Pública Y Participación   (Spain)

Author keywords

Breast neoplasm; Cervical neoplasm; Inequalities; Mammography; Pap smear; Prevention and control

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GEOGRAPHY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAMMOGRAPHY; MARRIAGE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PAPANICOLAOU TEST; PATIENT SATISFACTION; PRIORITY JOURNAL; PROBABILITY; SOCIAL ASPECT; SOCIAL CLASS; SOCIAL STATUS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WORK;

ADULT; AGED; BREAST NEOPLASMS; DEMOGRAPHY; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34547437259     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000236243.55866.b0     Document Type: Article

References (47)

1. Adams EK, Florence CS, Thorpe KE, Becker ER (2003). Preventive care. Female cancer screening, 1996-2000. Am J Prev Med 25:301-307.
2. Aro AR, de Koning HJ, Absetz P, Schreck M (1999). Psychosocial predictors of first attendance for organised mammography screening. J Med Screening 6:82-88.
3. Bailie R, Bourne D (1996). Surveillance for equity in cervical cytology screening. Int J Epidemiol 25:46-51.
4. Balearic Island Health Survey (ESIB) (2001). Department of Public Health, Balearic Department of Health and Consumer Affairs, Palma de Mallorca.
5. Baré ML, Montes J, Florensa R, Sentís M, Donoso L (2003). Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 12:487-494.
6. Benz CC, Clarke CA, Moore DH 2nd (2003). Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 12:1523-1527.
7. Borrás JM, Guillén M, Sánchez V, Juncà S, Vicente R (1999). Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev 8:427-434.
8. Breen N, Kessler L (1994). Changes in the use of screening mammography: evidence from the 1997 and 1990 national health interview surveys. Am J Public Health 84:62-67.
9. Breen N, Figueroa JB (1996). Stage of breast and cervical cancer diagnosis in disadvantaged neighbourhoods: a prevention policy perspective. Am J Prev Med 12:319-326.
10. Calle EE, Flanders D, Thun MJ, Marin LM (1993). Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 83:53-60.
11. Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ (1996). Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 78:1395-1402.
12. Ciatto S, Cecchini S, Isu A, Maggi A, Cammelli S (1992). Determinants of non attendance to mammographic screening. Analysis of a population sample of the screening program in the district of Florence. Tumori 78:22-25.
13. Clarke C, Glaser S, West D (2002). Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999. Breast Cancer Res 4:R13.
14. Conde Olasagasti J, Gonzalez Enriquez J (1995). Breast cancer mass screening with mammography [in Spanish]. Madrid: Health care technology assessment agency, The Carlos III Health Institute, Ministry of Health and Consumer Affairs.
15. Department of Health and Consumer Affairs - National Health Institute (2000). The Balearic breast cancer screening program [in Spanish]. Palma de Mallorca.
16. Faggiano F, Zannetti R, Costa G (1994). Cancer risk and social inequalities in Italy. J Epidemiol Comm Health 48:447-452.
17. Giordano L, Giorgi D, Fasolo G, Segnan N, Rosselli del Turco M (1996). Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMA). Tumori 82:1-8.
18. Harris RP, Fletcher SW, Gonzalez JJ, Lannin DR, Degnan D, Earp JA, Clark R (1991). Mammography and age: are we targeting the wrong women? A community survey of women and physicians. Cancer 67:2010-2014.
19. Higgins J, Wiles R (1992). Study of patients who choose private health care for treatment. Br J Gen Pract 42:326-329.
20. Hosmer DW, Lemeshow S (1989). Applied logistic regression. Canada: John Wiley & Sons.
21. Hsia J, Kemper E, Kiefe C, Apka J, Sofaer Sh, Pettinguer M, et al. (2000). The importance of health insurance as a determinant of cancer screening: evidence of the women's health initiative. Prev Med 31:261-270.
22. IARC (2004). Available at: http: www.iarc.fr. IARC Press release no. 151.
23. Katapodi MC, Lee KA, Facione NC, Dodd MJ (2004). Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38:388-402.
24. Katz SJ, Hofer TP (1994). Socio-economic disparities in preventive care persist despite universal coverage: breast and cervical cancer screening in Ontario and the United States. JAMA 272:530-534.
25. Kerlikowski K, Grady D, Rubin SM, Sandrock C, Ernster VL (1995). Efficacy of screening mammography: a metaanalysis. JAMA 273:149-154.
26. Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S, et al. Social class (1999). Race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 10:525-537.
27. Lagerlund M, Sparén P, Thurnjell E, Ekbom A, Lamber M (2000). Predictors of non attendance in a population based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev 9:25-33.
28. Link BG, Northridge ME, Pelan JC, Ganz ML (1998). Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q 76:375-398.
29. Luengo S, Lázaro P, Madero R, Alvira F, Fitch K, Azcona B, et al. (1996). Equity in access to mammography in Spain. Soc Sci Med 43:1263-1271.
30. Luengo Matos S, Muñoz van den Eynde A (2004). Use of pap smear for cervical cancer screening and factors related with its use in Spain [in Spanish]. Aten Primaria 33:229-236.
31. Makuc DM, Breen N, Freid V (1999). Low income, race and the use of mammography. HSR 34:229-239.
32. Ministerio de Sanidad y Consumo (1998). Instituto Nacional de la Salud. Programa Integral de atención a la mujer. Madrid.
33. Newell S, Girgis A, Sanson-Fisher R, Savolainen N (1999). The accuracy of self-reported health behaviours and risk factors relating to cancer and cardiovascular disease in the general population. A critical review. Am J Prev Med 17:211-229.
34. Official Journal of The European Union (2003). Council recommendation of 2 December 2003 on cancer screening [in Spanish] (2003/878/CE). L 327/34.
35. Parikh S, Brennan P, Boffetta P (2003). Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 105:687-691.
36. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors (2002). Cancer incidence in five continents. Vol. VIII. IARC Scientific Publications No. 155. Lyon: IARC.
37. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML (1998). Factors associated with women's adherence to mammography screening guidelines. Health Services Research 33:29-53.
38. Potvin L, Camirand J, Beland F (1995). Patterns of health services utilisation and mammography use among women aged 50 to 59 years in the Quebec Medicare System. Med Care 33:515-530.
39. http://www.programascancerdemama.org.
40. Rimpela AH, Pukkala EI (1987). Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med 24:601-606.
41. Rohlfs I, Borrell C, Pasarín MI, Plasència A (1999). The role of sociodemographic factors in preventive practices. The case of cervical and breast cancer. Eur J Public Health 9:278-284.
42. Ronco G, Segnan N, Ponti A (1991). Who has Pap tests? Variables associated with the use of Pap: absence of screening programmes. Int J Epidemiol 20:349-353.
43. Ronco G, Segnan N, Giordano L, Pilutti S, Senore C, Ponti A, Volantee R (1997). Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer 33:1262-1267.
44. Segnan N (1997). Socioeconomic status and cancer screening. IARC Sci Publ 138:369-376.
45. Segura Noguera JM, Porta Serra M, Guillà M, Casamitjana Abellà M, Castells Oliveres X (1998). Factors influencing coverage, response and participation in breast cancer screening program [in Spanish]. Med Clin (Barc) 111:251-256.
46. Segura Noguera JM, Castells X, Casamitjana M, Macià F, Ferrer F (2000). Utilisation of screening mammography as a preventive practice prior initiating a population-based breast cancer screening program. J Clin Epidemiol 52:595-603.
47. Working Group of the Spanish Society of Epidemiology (1995). The measure of social class of health science [in Spanish]. Barcelona: SG editors.